ALDX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Aldeyra Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.94 USD -2.72%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast ALDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALDX is 9.44 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

ALDX Lowest Forecast

Wall Street Target

ALDX Average Forecast

Wall Street Target

ALDX Highest Forecast

Wall Street Target

79% Upside

139% Upside

193% Upside

The latest public price target was made on Apr 3, 2024 by Justin Kim from Oppenheimer , who expects ALDX stock to rise by 154% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Justin Kim Oppenheimer	10 USD Upside 154%	4 weeks ago Apr 3, 2024	Oppenheimer Upgrades Aldeyra Therapeutics (ALDX) to Outperform StreetInsider
Matt Caufield H.C. Wainwright	10 USD Upside 154%	4 weeks ago Apr 2, 2024	H.C. Wainwright Reinstates Aldeyra Therapeutics (ALDX) at Buy StreetInsider
Unknown Analyst Citigroup	26 USD Upside 560%	1 year ago Jun 9, 2022	Citigroup Maintains Buy on Aldeyra Therapeutics, Raises Price Target to $26 Benzinga

Price Target	10 USD
Upside/Downside	154%

Price Target	10 USD
Upside/Downside	154%

Price Target	26 USD
Upside/Downside	560%

Shanghai OPM Biosciences Co Ltd

39% Upside

Madrigal Pharmaceuticals Inc

97% Upside

Beigene Ltd

46% Upside

Harpoon Therapeutics Inc

8% Upside

Shanghai OPM Biosciences Co Ltd

39% Upside

Madrigal Pharmaceuticals Inc

97% Upside

Beigene Ltd

46% Upside

Harpoon Therapeutics Inc

8% Upside

iNtRON Biotechnology Inc

135% Upside

Shanghai Junshi Biosciences Co Ltd

29% Upside

Xiamen Amoytop Biotech Co Ltd

17% Downside

ADMA Biologics Inc

31% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-5%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-59%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ALDX is 9.44 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

Join more than 133,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.